Abnormality of immune system physiology
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the dentition
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the intervertebral disk
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Adducted thumb
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Aqueductal Stenosis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cerebellar Hypoplasia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cerebral atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Chronic kidney disease stage 5
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Colon Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
In addition, we identified an FDA-approved bacteriostatic antibiotic, fusidic acid sodium salt (fusidic acid or FA) as an inhibitor of PRPK, and show that FA combined with 5-fluorouracil (5-FU) inhibited PRPK activity and colon cancer metastasis to the lung in mice.
|
29483219 |
2018 |
Colorectal Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
CREB-miR-630-BCL2L2 and TP53RK comprise a novel signaling cascade regulating radiosensitivity in CRC cell lines by inducing cell apoptosis and death.
|
26263387 |
2015 |
Delayed speech and language development
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Diffuse mesangial sclerosis (disorder)
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dwarfism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Electroencephalogram abnormal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Feeding difficulties
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Fetal Growth Retardation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Flexion contracture of proximal interphalangeal joint
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Galloway Mowat syndrome
|
0.520 |
Biomarker
|
disease |
CTD_human |
Here we identified recessive mutations in OSGEP, TP53RK, TPRKB, and LAGE3, genes encoding the four subunits of the KEOPS complex, in 37 individuals from 32 families with GAMOS.
|
28805828 |
2017 |
Galloway Mowat syndrome
|
0.520 |
GeneticVariation
|
disease |
BEFREE |
To our knowledge, this is only the second report on GAMOS in association with a TP53RK mutation.
|
30053862 |
2018 |
Galloway Mowat syndrome
|
0.520 |
GermlineCausalMutation
|
disease |
ORPHANET |
Here we identified recessive mutations in OSGEP, TP53RK, TPRKB, and LAGE3, genes encoding the four subunits of the KEOPS complex, in 37 individuals from 32 families with GAMOS.
|
28805828 |
2017 |
Galloway Mowat syndrome
|
0.520 |
GeneticVariation
|
disease |
BEFREE |
Galloway-Mowat syndrome (GAMOS) (OMIM #251300) is a severe autosomal recessive disease characterized by the combination of early-onset steroid-resistant nephrotic syndrome (SRNS) and microcephaly with brain anomalies caused by WDR73 as well as OSGEP, TP53RK, TPRKB, or LAGE3 mutations.
|
30141175 |
2018 |
GALLOWAY-MOWAT SYNDROME 4
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
GALLOWAY-MOWAT SYNDROME 4
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly.
|
28805828 |
2017 |
GALLOWAY-MOWAT SYNDROME 4
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly.
|
28805828 |
2017 |
GALLOWAY-MOWAT SYNDROME 4
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in KEOPS-complex genes cause nephrotic syndrome with primary microcephaly.
|
28805828 |
2017 |